Show simple item record

dc.contributor.authorMas, Sebastián
dc.contributor.authorBosch-Panadero, Enrique
dc.contributor.authorAbaigar, Pedro
dc.contributor.authorCamarero, Vanesa
dc.contributor.authorMahillo, Ignacio
dc.contributor.authorCivantos, Esther
dc.contributor.authorSanchez-Ospina, Didier
dc.contributor.authorRuiz-Priego, Alberto
dc.contributor.authorEgido, Jesus
dc.contributor.authorOrtiz Arduán, Alberto 
dc.contributor.authorGonzález-Parra, Emilio
dc.contributor.otherUAM. Departamento de Medicinaes_ES
dc.contributor.otherInstituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD)es_ES
dc.date.accessioned2018-05-23T17:32:44Z
dc.date.available2018-05-23T17:32:44Z
dc.date.issued2018-03-01
dc.identifier.citationPLoS ONE 13.3 (2018): e0193288en_US
dc.identifier.issn1932-6203es_ES
dc.identifier.urihttp://hdl.handle.net/10486/682504
dc.description.abstractIntroduction: Bisphenol A (BPA) is an ubiquitous environmental toxin that is also found in dialyzers. Online hemodiafiltration (OL-HDF) more efficiently clears high molecular weight molecules, and this may improve BPA clearance. However, the BPA contents of dialysis membranes may be a source of BPA loading during OL-HDF. Methods A prospective study assessed plasma BPA levels in OL-HDF patients using BPA-free (polynephron) or BPA-containing (polysulfone) dialyzers in a crossover design with two arms, after a run-in OL-HDF period of at least 6 months with the same membrane: 31 patients on polynephron at baseline were switched to polysulfone membranes for 3 months (polynephron-to-polysulfone) and 29 patients on polysulfone were switched to polynephron for 3 months (polysulfone-to-polynephron). Results After a run-in OL-HDF period of at least 6 months with the same membrane, baseline predialysis BPA was lower in patients on polynephron (8.79±7.97 ng/ml) than in those on polysulfone (23.42±20.38 ng/mL, p < 0.01), but still higher than in healthy controls ( < 2 ng/mL). After 3 months of polynephron-to-polysulfone switch, BPA was unchanged (8.98±7.88 to 11.14±15.98 ng/mL, ns) while it decreased on the polysulfone-to-polynephron group (23.42±20.38 to 11.41±12.38 ng/mL, p < 0.01). Conclusion OL-HDF for 3 months with BPA-free dialyzer membranes was associated to a significant decrease in predialysis BPA levels when compared to baseline BPA levels while on a BPA-containing membraneen_US
dc.description.sponsorshipThe Renal, Vascular and Diabetes Laboratory is funded by Ministerio de Economia, Industria y competitividad: FIS ISCIII FEDER funds PI16/01298, PI15/00298, PI16/02057, PI16/01900, SCIII-RETIC REDinREN RD12/0021 RD16/0009, CYTED IBERERC and Sociedad Madrileña de Nefrologia, Programa Intensificación Actividad Investigadora (ISCIII) to AO. This work was supported by a grant from Nipro corporation, and Fundacioón Renal Íñigo Álvarez de Toledo (FRIAT)en_US
dc.format.extent11 pag.es_ES
dc.format.mimetypeapplication/pdfen
dc.language.isoengen
dc.publisherPublic Library of Sciencees_ES
dc.relation.ispartofPLos ONEes_ES
dc.rights© 2018 Mas et al.es_ES
dc.subject.otherBisphenol Aen_US
dc.subject.otherOnline hemodiafiltration (OL-HDF)en_US
dc.subject.otherDialysis membranesen_US
dc.titleInfluence of dialysis membrane composition on plasma bisphenol A levels during online hemodiafiltrationen_US
dc.typearticleen
dc.subject.ecienciaMedicinaes_ES
dc.relation.publisherversionhttps://doi.org/10.1371/journal.pone.0193288es_ES
dc.identifier.doi10.1371/journal.pone.0193288es_ES
dc.identifier.publicationfirstpagee0193288-1es_ES
dc.identifier.publicationissue3es_ES
dc.identifier.publicationlastpagee0193288-11es_ES
dc.identifier.publicationvolume13es_ES
dc.relation.projectIDGobierno de España. PI16/01298es_ES
dc.relation.projectIDGobierno de España. PI15/00298es_ES
dc.relation.projectIDGobierno de España. PI16/02057es_ES
dc.relation.projectIDGobierno de España. PI16/01900es_ES
dc.relation.projectIDGobierno de España. RD12/0021es_ES
dc.relation.projectIDGobierno de España. RD16/0009es_ES
dc.type.versioninfo:eu-repo/semantics/publishedVersionen
dc.rights.ccReconocimientoes_ES
dc.rights.accessRightsopenAccessen
dc.facultadUAMFacultad de Medicina
dc.institutoUAMInstituto de Investigación Sanitaria Fundación Jiménez Díaz (ISS-FJD)


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record